Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock

被引：0
|
作者：
S Sobieszczyk
GH Breborowicz
B Kubiaczyk
T Opala
机构：
[1] University of Medical Sciences,Laboratory of Cardiovascular and Haemostasis Disorders, Department of Mother and Child Health
[2] University of Medical Sciences,Department of Perinatology and Gynaecology
[3] University of Medical Sciences,Department of Mother and Child Health
来源：
Critical Care | / 7卷 / Suppl 2期
关键词：
Emergency Medicine; Conventional Method; Prothrombin; Small Dose; Hemorrhagic Shock;
D O I：
10.1186/cc1994
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Activated recombinant factor VII (rFVIIa)
    Grottke, Oliver
    Henzler, Dietrich
    Rossaint, Rolf
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2010, 24 (01) : 95 - 106
  • [2] Pharmacokinetics of recombinant activated factor VII (rFVIIa)
    Erhardtsen, E
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 385 - 391
  • [3] Recombinant activated factor VII (rFVIIa/NovoSeven®) in intractable haemorrhage:: use of a clinical scoring system to predict outcome
    Biss, TT
    Hanley, JP
    VOX SANGUINIS, 2006, 90 (01) : 45 - 52
  • [4] Recombinant activated factor VII (rFVIIa-NovoSeven®-NovoNordisk) treatment of bleeding complications in intensive care unit
    A Bonadona
    P Pavese
    R Hamidfar
    G Pernod
    T Stouls
    C Pison
    C Letoublon
    D Barnoud
    Critical Care, 6 (Suppl 1):
  • [5] The comparison of efficacy between recombinant activated factor VII (ARYOSEVEN®) and NOVOSEVEN® in patients with congenital factor VII deficiency
    Faranoush, M.
    Hassan, A.
    Toogeh, G.
    Karimi, M.
    Eshghi, P.
    Managchi, M. R.
    Hamid, H.
    Kamyar, K.
    Heshmat, R.
    Keykhahi, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1198 - 1199
  • [6] A COMPARISON OF EFFICACY BETWEEN RECOMBINANT ACTIVATED FACTOR VII (ARYOSEVEN™) AND NOVOSEVEN® IN PATIENTS WITH CONGENTIAL FACTOR VII DEFICIENCY
    Abolghasemi, Hasan
    Khoein, Babak
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E59 - E59
  • [7] Intraoperative use of recombinant activated factor VII (rFVIIa)
    De Gasperi, A.
    MINERVA ANESTESIOLOGICA, 2006, 72 (06) : 489 - 494
  • [8] Safety and Efficacy of Recombinant Activated Factor VII (Novoseven) Administration in Pediatric ECMO Patients
    Kasniya, G.
    Salisbury, C.
    Heard, M. L.
    Maher, K.
    Deshpande, S. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S421 - S422
  • [9] Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
    Smith, Jason E.
    Watts, S.
    Spear, A. M.
    Wilson, C.
    Kirkman, E.
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2019, 165 (01) : 51 - 56
  • [10] Activated recombinant factor VII (rFVIIa/NovoSeven®) in the treatment of bleeding complications following hematopoietic stem cell transplantation (HSCT)
    Brenner, B
    Pihusch, M
    Bacigalupo, A
    Szer, J
    Prondzinski, MV
    Gaspar-Blaudschun, B
    Hyveled, L
    BLOOD, 2004, 104 (11) : 321A - 322A
12345